Betty Allen Gynecologic Cancer Foundation
Your Survival is Our Mission
Recent studies conducted in the United States and in Europe have effectively demonstrated the potential of a Parasortix-based blood test in outperforming current tests used to diagnose ovarian cancer. ANGLE, a world-leading liquid biopsy company, has currently invented a cell separation technology ... Read More »
SOURCE: FindaTopDoc.com
By: WGRZ Staff, Kelly Dudzik BUFFALO, N.Y. — Roswell Park, Inova Health System, Mayo Clinic, and MD Anderson are teaming up to develop an ovarian cancer detection test. The researchers are collaborating to create a test that would identify precancerous STIC lesions in their early ... Read More »
SOURCE: WGRZ-NBC2
ROCK HILL, S.C. (CN2 TODAY) Cancer Free. Two words that change everything for those who have been battling the disease. Here at CN2 we have been following the story of Brooklyn Channell since 2011. At just nine years old she was diagnosed with Ovarian Cancer. After fighting a long battle, losing ... Read More »
SOURCE: CN2.com
By Maya Oppenheim A blood test may detect ovarian cancer up to two years earlier, a new study has found. Scientists developed a simple screening method involving a biomarker made up of four proteins seen together. The study, published in the journal Nature, involved the analysis of blood ... Read More »
SOURCE: Independent.co.uk
DENVER (CBSMiami) – Nearly 14,000 women will die from ovarian cancer in 2019. Now, new research has found that women who use IUDs for birth control may be lowering their ovarian cancer risk. For five years, Amy Dickson Plache has bravely battled ovarian cancer with chemotherapy, clinical trials, ... Read More »
SOURCE: CBS Miami
By Denise Heady, University of California, Los Angeles Out of the 22,240 women in the United States who are diagnosed with ovarian cancer every year, only about 47 percent survive longer than five years. But Dr. Beth Karlan, the newly appointed director of cancer population genetics at UCLA's ... Read More »
SOURCE: Medical Express
By Katie O'Malley A “game-changing” drug for women living with ovarian cancer has received approval as a first stage treatment on the NHS. The drug, named Lynparza (olaparib), is being made available through the Cancer Drugs Fund to help women with a genetic form of the cancer. The ... Read More »
SOURCE: Independent.co.uk
By Anna Smith AstraZeneca and MSD have announced that Lynparza (olaparib) is now recommended for use within the Cancer Drugs Fund for women with newly diagnosed advancedBRCA-mutated ovarian cancer. The national Institute for Health and Care Excellence (NICE) recommended the drug specifically ... Read More »
SOURCE: PharmaTimes Online
April 9, 2019, by NCI Staff Tests for inherited genetic mutations can provide women diagnosed with ovarian or breast cancer with important information that can have implications for family members and potentially guide treatment decisions and longer-term screening for second cancers. However, ... Read More »
SOURCE: National Cancer Institute
May 2, 2018, by NCI Staff Researchers have shown that an experimental screening test can detect some endometrial and ovarian cancers at their early, more treatable stages. The test, called PapSEEK, is a type of liquid biopsy that identifies cancer-related alterations in DNA obtained from ... Read More »
SOURCE: National Cancer Institute
Mailing Address:
13300-56 S. Cleveland Ave.
Ft. Myers, FL 33907
Phone: (239) 935 – 8325
Email: info@gyncancerfl.org
